Revolutionizing Cancer Care? Dr. John Campbell on Immune Modulation, Low-Dose Naltrexone & Alternative Therapies

Revolutionizing Cancer Care? Dr. John Campbell on Immune Modulation, Low-Dose Naltrexone & Alternative TherapiesDr. John Campbell and his guest explore emerging perspectives on cancer care, immune modulation, and low-dose therapies. The discussion covers Immunomodulin 101, a heat-killed bacterium intended to stimulate the innate immune system, and low-dose naltrexone (LDN), which has been studied for its potential effects on inflammation and immune function. They argue that these lower-cost treatments deserve greater attention while also criticizing aspects of the pharmaceutical industry and public health responses during the COVID-19 pandemic. This interview presents their viewpoints on alternative approaches to supporting immune health and managing chronic disease.#Cancer #CancerResearch #ImmuneSystem #ImmuneModulation #LowDoseNaltrexone #LDN #AlternativeMedicine #IntegrativeMedicine #DrJohnCampbell #Health #MedicalResearch #ChronicDisease #Wellness #Healthcare #Podcast